Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
69
70
Next >
Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions
February 27, 2023
Via
Benzinga
Here's How Much $1000 Invested In Merck & Co 5 Years Ago Would Be Worth Today
February 27, 2023
Via
Benzinga
'Here We Go Again': Seagen Soars As Pfizer Reportedly Mulls A Takeover
February 27, 2023
The potential deal follows rumors last year that Merck could buy Seagen.
Via
Investor's Business Daily
Seagen Stock Soars On Pfizer Takeover Talks: What's Going On?
February 27, 2023
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday following reports indicating pharmaceutical giant Pfizer Inc (NYSE:
Via
Benzinga
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
February 26, 2023
Via
Benzinga
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 25
February 25, 2023
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Feb. 20-24.
Via
Talk Markets
US Senators Warren, Sanders Urge 'Close Scrutiny' On Merck's Keytruda-Related Patents
February 24, 2023
Via
Benzinga
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
February 24, 2023
Via
Benzinga
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
February 24, 2023
Startling cancer vaccine results from Moderna may point to the next big thing in biotech.
Via
Investor's Business Daily
Don't Get Panicked Into Selling Off Merck Shares
February 24, 2023
The current drop in 2023 sales likely won't matter in the long term.
Via
The Motley Fool
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Via
Benzinga
Moderna Pops After FDA Grants Its Cancer Vaccine A Breakthrough Designation
February 22, 2023
The companies could see a speedier review process.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via
Benzinga
Expert Ratings for Merck & Co
February 22, 2023
Via
Benzinga
Merck's COVID-19 Treatment Fails To Prevent Infection In Household Exposure
February 21, 2023
Via
Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.
Via
The Motley Fool
Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data
February 21, 2023
Prominent market commentator Jim Cramer on Tuesday suggested a six-point checklist of events that must happen before declaring an end to the market sell-off.
Via
Benzinga
3 Large-Cap Biotech Stocks to Hold for the Long Haul
February 19, 2023
These three large-cap biotech stocks survived or went up in 2022 when most of the market went down by double digits.
Via
InvestorPlace
2022 Annual Review
February 18, 2023
In this annual review, I look at my dividend portfolio's performance as measured by dividend income, dividend increases, annualized returns, and rate of return. I also share some highlights of the past...
Via
Talk Markets
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
February 17, 2023
We asked ChatGPT to name various types of stocks to buy. Can the latest artificial intelligence craze get things right?
Via
InvestorPlace
Why Shares of Organon Fell 15% Thursday
February 16, 2023
The company reported fourth-quarter and year-end financials.
Via
The Motley Fool
Should Income Investors Buy This Dow Jones Stock?
February 17, 2023
This drugmaker boasts an impressive product portfolio and pipeline.
Via
The Motley Fool
Merck Says Keytruda/Chemo Combo Improved Overall Survival Compared To Chemo Alone In Gastric Cancer Settings
February 16, 2023
Via
Benzinga
2 Ultra-Safe Dividend Stocks to Buy Right Now
February 16, 2023
These two dividend stocks are top buys for investors concerned about an economic slowdown.
Via
The Motley Fool
2 Market-Beating Dividend Stocks to Buy With $500
February 16, 2023
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
Via
The Motley Fool
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
Cannabis companies of all sizes are struggling to increase their profit margins and to make that happen, they're implementing different strategies. Lowering prices and premiumizing products are among...
Via
Benzinga
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
February 15, 2023
The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
BioXcel Therapeutics Unveils Complete Data From BXCL701/Keytruda Combo Study In Prostate Cancer Subtype
February 14, 2023
Via
Benzinga
Acurx is Setting a High Bar for New Treatments in C. diff
February 14, 2023
A New Gold Standard for C. diff Therapy Could be in the Offing; Next Data Release Expected in 2Q23
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.